Advertisement
Home Tags Respiratory Problems: Misc.

Tag: Respiratory Problems: Misc.

Fiber intake is associated with measures of lung function in U.S. adults

Fiber Intake Linked to Measures of Lung Function

0
Higher FEV1 and FVC for participants in the highest versus the lowest quartile of fiber intake
Inhibition of mammalian target of rapamycin by rapamycin restores corticosteroid sensitivity in patients with chronic obstructive pulmonary disease

Inhibition of mTOR Restores Corticosteroid Sensitivity in COPD

0
mTOR inhibition by rapamycin restores corticosteroid sensitivity via c-Jun expression inhibition
New recommendations have been developed for antithrombotic therapy for venous thromboembolism. The Antithrombotic Therapy for VTE Disease: CHEST Guideline was published online Jan. 7 in CHEST.

Recommendations Developed for Antithrombotic Tx in VTE

0
Guidelines updated for 12 topics; new recommendations address three new topics
Chronic pulmonary silicone embolism related to saline breast implants has been detailed in a letter to the editor published in the January issue of the Annals of the American Thoracic Society.

Breast Implants Linked to Chronic Pulmonary Silicone Embolism

0
Case report describes chronic pulmonary silicone embolism related to saline implants

December 2015 Briefing – Pulmonology

0
Here are what the editors at HealthDay consider to be the most important developments in Pulmonology for December 2015. This roundup includes the latest...
For patients with pulmonary arterial hypertension

Selexipag Linked to Reduced Risk of Death, Complications in PAH

0
Reduced risk of composite of death or pulmonary arterial hypertension-linked complications
A minority of patients discharged with chronic obstructive pulmonary disease receive pharmacologic treatment for tobacco use

Few Get Rx to Help Quit Smoking After COPD Hospitalization

0
Treatment not associated with cessation at six to 12 months; differences between medications
Uptravi (selexipag) has been approved by the U.S. Food and Drug Administration to treat adults with pulmonary arterial hypertension.

FDA Approves Uptravi for Pulmonary Arterial Hypertension

0
Drug found to limit worsening of the disease and reduce the need for hospitalization
About 20 percent of patients administered fresh frozen plasma (FFP) to reverse warfarin anticoagulation develop pulmonary complications

Dose-Linked Pulmonary Complications After FFP Infusion

0
In warfarin reversal, highest risk with more than three units of fresh frozen plasma
For patients with sleep disordered breathing

Expiratory Snoring Predicts COPD in Sleep Disordered Breathing

0
Linear combination of mean oxygen saturation, expiratory breathing predicts FEV1